Actinium Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Actinium Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 14, 2024 was 31.2M shares, a 13.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 31.2M +3.78M +13.8% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 31.2M +4.16M +15.4% Aug 2, 2024 10-Q 2024-08-05
Q1 2024 29.4M +3.67M +14.3% Mar 27, 2024 10-K 2024-03-29
Q3 2023 27.4M +1.93M +7.57% Nov 1, 2023 10-Q 2023-11-02
Q2 2023 27M +1.81M +7.2% Aug 14, 2023 10-Q 2023-08-14
Q1 2023 25.7M +3.59M +16.2% Mar 31, 2023 10-K 2023-03-31
Q3 2022 25.5M +3.45M +15.7% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 25.2M +3.85M +18.1% Aug 12, 2022 10-Q 2022-08-12
Q1 2022 22.1M +2.9M +15.1% Mar 25, 2022 10-K 2022-03-25
Q3 2021 22M +8.44M +62.2% Nov 12, 2021 10-Q 2021-11-12
Q2 2021 21.3M -374M -94.6% Jul 28, 2021 10-Q 2021-07-30
Q1 2021 19.2M -284M -93.7% Mar 31, 2021 10-K 2021-03-31
Q3 2020 13.6M -151M -91.8% Oct 23, 2020 10-Q 2020-10-23
Q2 2020 395M +233M +143% Jun 29, 2020 10-Q 2020-06-30
Q1 2020 303M +184M +155% May 7, 2020 10-K 2020-05-08
Q3 2019 165M +49M +42.4% Nov 12, 2019 10-Q 2019-11-12
Q2 2019 162M +52M +47% Aug 9, 2019 10-Q 2019-08-09
Q1 2019 119M +8.94M +8.11% Mar 15, 2019 10-K 2019-03-15
Q3 2018 116M +35.7M +44.6% Nov 9, 2018 10-Q 2018-11-09
Q2 2018 110M +30.4M +38% Aug 9, 2018 10-Q 2018-08-09
Q1 2018 110M +54.4M +97.5% Mar 16, 2018 10-K 2018-03-16
Q3 2017 80M +24.3M +43.6% Nov 3, 2017 10-Q 2017-11-03
Q2 2017 80M +32.3M +67.7% Aug 4, 2017 10-Q 2017-08-04
Q1 2017 55.8M +11.4M +25.7% Mar 16, 2017 10-K 2017-03-16
Q3 2016 55.7M +13.7M +32.7% Oct 28, 2016 10-Q 2016-10-28
Q2 2016 47.7M +7.08M +17.4% Jul 28, 2016 10-Q 2016-07-29
Q1 2016 44.4M +8.91M +25.1% Mar 10, 2016 10-K 2016-03-11
Q3 2015 42M +12M +40% Oct 29, 2015 10-Q 2015-10-30
Q2 2015 40.6M +12.5M +44.4% Aug 6, 2015 10-Q 2015-08-07
Q1 2015 35.5M +10.2M +40.1% Mar 16, 2015 10-K 2015-03-16
Q3 2014 30M +6.35M +26.8% Oct 30, 2014 10-Q 2014-10-31
Q2 2014 28.1M +11.8M +72.7% Aug 11, 2014 10-Q 2014-08-12
Q1 2014 25.3M +13.3M +110% Feb 26, 2014 10-K 2014-02-28
Q3 2013 23.7M +12.5M +112% Nov 12, 2013 10-Q 2013-11-14
Q2 2013 16.3M +5.14M +46.1% Aug 12, 2013 10-Q 2013-08-13
Q1 2013 12.1M +898K +8.05% Mar 26, 2013 10-K 2013-03-29
Q3 2012 11.2M 0 0% Oct 30, 2012 10-Q 2012-11-14
Q2 2012 11.2M 0 0% Aug 6, 2012 10-Q/A 2012-08-29
Q1 2012 11.2M Apr 17, 2012 10-Q 2012-04-23
Q3 2011 11.2M Nov 4, 2011 10-Q 2011-11-14
Q2 2011 11.2M Aug 8, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.